Literature DB >> 326681

Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy.

P J Stallman, R C Aalberse, P C Brühl, E H van Elven.   

Abstract

In previous experiments a correlation was found between the amount of IgE on human basophils and the IgE serum level. The results of these experiments are shown to fit a free exchange model with an approximately constant K-value. We investigated whether the free IgE-receptors on the basophils, which should be present according to this model, could be saturated by incubating the cell suspensions with IgE myeloma protein or with sera from patients with an elevated IgE serum level. Various incubation conditions were applied in sensitizing the leukocytes, and cells from both atopic and nonatopic subjects were used for testing, but no increase in basophil-bound IgE could be measured with the quantitative immunofluorescence technique. Nor could we demonstrate a significant dissociation of cell-bound IgE in a period of 24 h. Therefore another hypothesis is put forward, in which receptor turnover is taken into account: we assumed that that free receptors on the basophils had a shorter functional half-life, than the half-life of the IgE-receptor complexes. This model would explain the contradictory results mentioned above.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326681     DOI: 10.1159/000231849

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  2 in total

1.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

2.  IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions.

Authors:  M Yamaguchi; C S Lantz; H C Oettgen; I M Katona; T Fleming; I Miyajima; J P Kinet; S J Galli
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.